Paper · 8985336
Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.
Chow YH and 4 others. J Virol, 1997. Cited by 203 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. Papers, record 8985336. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8985336
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA, Viral | Major topic |
| Hepatitis B | Major topic |
| Hepatitis B Surface Antigens | Major topic |
| Hepatitis B Vaccines | Major topic |
| Hepatitis B virus | Major topic |
| Interleukin-2 | Major topic |
| Protein Precursors | Major topic |
| Vaccines, DNA | Major topic |
| Animals | |
| Cell Line | |
| Female | |
| Gene Expression | |
| Genetic Engineering | |
| Hepatitis B Antibodies | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Plasmids | |
| Recombinant Fusion Proteins | |
| T-Lymphocytes |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8,360,497 | Induction of antibodies to a kappa V region by gene immunization. | J Immunol | 1993 | https://conductscience.org/library/papers/8360497 | PubMed |
| 2 | 7,884,908 | DNA vaccination against persistent viral infection. | J Virol | 1995 | https://conductscience.org/library/papers/7884908 | PubMed |
| 3 | 8,662,521 | Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. | Science | 1996 | https://conductscience.org/library/papers/8662521 | PubMed |
| 4 | 8,598,468 | Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. | J Immunol | 1996 | https://conductscience.org/library/papers/8598468 | PubMed |
| 5 | 7,912,089 | Acquisition of lymphokine-producing phenotype by CD4+ T cells. | Annu Rev Immunol | 1994 | https://conductscience.org/library/papers/7912089 | PubMed |
| 6 | 7,884,923 | DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. | J Virol | 1995 | https://conductscience.org/library/papers/7884923 | PubMed |
| 7 | 7,895,169 | Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. | Immunity | 1995 | https://conductscience.org/library/papers/7895169 | PubMed |
| 8 | 7,747,423 | Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). | Virology | 1995 | https://conductscience.org/library/papers/7747423 | PubMed |
| 9 | 7,777,503 | DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7777503 | PubMed |
| 10 | 7,778,289 | Immune responses to nucleic acid vaccines to rabies virus. | Virology | 1995 | https://conductscience.org/library/papers/7778289 | PubMed |
1 to 10 of 56
See all 56 referencesCited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 203 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,742,318 | Construction and immunological evaluation of recombinant adenovirus vaccines of new novel NADC34-PRRSV strains in pigs. | Front Vet Sci | 2024 | https://conductscience.org/library/papers/39742318 | PubMed |
| 26,042,527 | The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses. | Hum Vaccin Immunother | 2015 | https://conductscience.org/library/papers/26042527 | PubMed |
| 24,643,207 | Cimetidine synergizes with Praziquantel to enhance the immune response of HBV DNA vaccine via activating cytotoxic CD8(+) T cell. | Hum Vaccin Immunother | 2014 | https://conductscience.org/library/papers/24643207 | PubMed |
| 24,603,502 | Highly efficient expression of interleukin-2 under the control of rabbit β-globin intron II gene enhances protective immune responses of porcine reproductive and respiratory syndrome (PRRS) DNA vaccine in pigs. | PLoS One | 2014 | https://conductscience.org/library/papers/24603502 | PubMed |
| 24,053,449 | Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus. | Virol J | 2013 | https://conductscience.org/library/papers/24053449 | PubMed |
| 24,031,690 | Immune response to dna vaccine expressing transferrin binding protein a gene of Pasteurella multocida. | Braz J Microbiol | 2011 | https://conductscience.org/library/papers/24031690 | PubMed |
| 21,508,173 | Adjuvant activity of the catalytic A1 domain of cholera toxin for retroviral antigens delivered by GeneGun. | Clin Vaccine Immunol | 2011 | https://conductscience.org/library/papers/21508173 | PubMed |
| 21,350,664 | Coexpression of PPE 34.9 Antigen of Mycobacterium avium subsp. Paratuberculosis with Murine Interferon Gamma in HeLa Cell Line and Study of Their Immunogenicity in Murine Model. | Biotechnol Res Int | 2011 | https://conductscience.org/library/papers/21350664 | PubMed |
| 19,199,070 | Coexpression of 16.8 kDa antigen of Mycobacterium avium paratuberculosis and murine gamma interferon in a bicistronic vector and studies on its potential as DNA vaccine. | Vet Res Commun | 2009 | https://conductscience.org/library/papers/19199070 | PubMed |
| 18,329,109 | Enhancement of the immunogenicity of an infectious bronchitis virus DNA vaccine by a bicistronic plasmid encoding nucleocapsid protein and interleukin-2. | J Virol Methods | 2008 | https://conductscience.org/library/papers/18329109 | PubMed |
1 to 10 of 34
See all 34 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL2 | 3,558 | PubTator's text mining | https://conductscience.org/library/genes/3558 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8985336
GET https://conductscience.org/api/papers/v1/8985336/references?page=2